2022 ACR/EULAR Giant Cell Arteritis Classification Criteria
2022 ACR/EULAR Giant Cell Arteritis Classification Criteria - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
Open the 2022 ACR/EULAR Giant Cell Arteritis Classification Criteria → Runs in your browser. No signup, no tracking.
What this is
2022 ACR/EULAR Giant Cell Arteritis Classification Criteria is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. 2022 ACR/EULAR Giant Cell Arteritis Classification Criteria - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
When to use it
Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.
References
Ponte C, Grayson PC, Robson JC, et al. 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis. Ann Rheum Dis. 2022;81(12):1647-1653. Read the source ↗
Worked example: 2022 ACR/EULAR 6/25 — ≥ 6: classify as giant cell arteritis.
Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.